Friday 6 November 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024.

Revenue: +10.6%
EPS: −104.4%
Free cash flow: −69.3%
Total debt: +16.0%

Quarter to September 2026, against a year earlier

248.54 4.61 +1.89%

Follow BIIB

Alert me

Market cap: $36.1B
P/E: 104×
Fwd P/E: 47.4×
Dividend yield: —
F-score: 4/9
Altman Z: 3.13
Beneish M: −2.67
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Biogen Inc. (BIIB) Book value per share

Alert me on Book value per share

Biogen Inc.'s book value per share at the end of fiscal 2025 was 125×, up 8.55% from 115× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 128×. Over the past ten years it has ranged from 40.6× (fiscal 2015) to 125× (fiscal 2025) — the current reading is the highest in ten years. Biogen Inc. ranks 1st of 21 Drug Manufacturers General companies by book value per share.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BIIB/book-value-per-share" width="100%" height="360" style="border:0" loading="lazy" title="Biogen Inc. book value per share, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BIIB/metrics/book-value-per-share">Biogen Inc. (BIIB) book value per share — stockrow.com</a></p>

Period	Book value per share	Change
FY2025	125×	8.55%
FY2024	115×	12.25%
FY2023	102×	11.00%
FY2022	92.1×	25.36%
FY2021	73.5×	10.68%
FY2020	66.4×	(6.84%)
FY2019	71.3×	12.10%
FY2018	63.6×	7.33%
FY2017	59.3×	6.70%
FY2016	55.5×	36.66%

Period	Book value per share	Change
Sep 2026	128×	0.33%
Jun 2026	128×	0.71%
Mar 2026	127×	1.68%
Dec 2025	125×	0.34%
43 more quarters	Free account

Against its own ten years

Low 40.6× High 125×

Ten-year median 71.3×

Current reading's percentile 100

Company	Book value per share
BIIB Biogen Inc.	128×
SNY Sanofi compare	35.1×
AZN AstraZeneca PLC compare	33.4×
AMGN Amgen Inc. compare	26.5×
PFE Pfizer Inc. compare	15.7×
GSK GSK PLC Sponsored ADR compare	12.3×
BMY Bristol Myers Squibb Company compare	11.5×
GILD Gilead Sciences, Inc. compare	10.4×
NVO Novo Nordisk A/S compare	7.8×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

Biogen Inc. (BIIB) Book value per share

Book value per share, annual

Annual newest first

Quarterly newest first

Against its own ten years

Book value per share against peers

What Book value per share is

More on BIIB

Book value per share, annual

Annual newest first

Quarterly newest first

Against its own ten years

Book value per share against peers

What Book value per share is

More on BIIB

Stockrow Weekly